You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-operative Hepatocellular Carcinoma.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitamin D Deficiency, Hepatocellular Carcinoma, Perioperative Complication Trial (Vitamin D, Placebo)

Not yet recruiting
  • Vitamin D Deficiency
  • +2 more
  • Vitamin D
  • Placebo
  • (no location specified)
Dec 6, 2022

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Hepatocellular Carcinoma Trial in Hershey (Lumason)

Completed
  • Hepatocellular Carcinoma
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center
Oct 17, 2022

Cell-free DNA From Junction of Hepatitis B Virus Integration in

Active, not recruiting
  • Hepatocellular Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 10, 2023

    Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
      • (no location specified)
      Dec 19, 2022

      Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)

      Not yet recruiting
      • Hepatocellular Carcinoma Non-resectable
      • BioPearl™
      • Brussels, Belgium
      • +5 more
      Jun 20, 2023

      Hepatocellular Carcinoma, TACE, Anlotinib Trial in Lanzhou, Xi'an (Anlotinib Hydrochloride, TACE)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Anlotinib Hydrochloride
      • TACE
      • Lanzhou, Gansu, China
      • +3 more
      Jan 12, 2023

      Interpretable Deep Learning Framework for Post-Hepatectomy Liver

      Not yet recruiting
      • Post-hepatectomy Liver Failure
      • +2 more
      • The explanation of deep learning framework (VAE-MLP) , including counterfactual explanations and layerwise relevance propagation
      • +2 more
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital of Sun Yat-Sen University
      Sep 4, 2023

      Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)

      Recruiting
      • Head and Neck Carcinoma
      • Elective nodal de-escalation arm
      • Cairo, Egypt
        National Cancer Institute
      Dec 6, 2022

      Liver Cancer, Post Ablation Syndrome Trial in Tainan (The skin lidocaine patch., Placebo)

      Completed
      • Liver Cancer
      • Post Ablation Syndrome
      • The skin lidocaine patch.
      • Placebo
      • Tainan, Taiwan
        National Cheng Kung University Hospital
      Feb 7, 2023

      Calculate the Radiation-absorbed Dose of Tc-99m MAA.

      Recruiting
      • Hepatocellular Carcinoma
      • Technetium-99m macroaggregated albumin (Tc-99m MAA)
      • Chicago, Illinois
        Northwestern University
      Jan 17, 2023

      Abbreviated Magnetic Resonance Imaging asScreening Tool for

      Recruiting
      • Hepatocellular Carcinoma
      • MRI
      • Chandigarh, Punjab, India
        Post Graduate Institute of Medical Education and Research
      Feb 6, 2023

      Role of Pre-operative CPET in Pancreatoduodenectomy

      Completed
      • Pancreas Cancer
      • Periampullary Carcinoma
        • Blackburn, Lancashire, United Kingdom
          East Lancashire Hospitals NHS Trust
        Sep 28, 2023

        Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))

        Completed
        • Hepatocellular Carcinoma
        • TCR-T
        • No intervention and TCR-T (at crossover)
        • Guangzhou, Guangdong, China
          The First Affiliated Hospital, Sun-Yat Sen University
        Jun 27, 2022

        Pre-transplant ICI Exposure and Post-transplant Graft Rejection

        Recruiting
        • Graft Rejection
        • +3 more
        • Immune checkpoint inhibitor
        • Guangzhou, Guangdong, China
          Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
        Jun 21, 2023

        Peritoneal Carcinomatosis, Appendiceal Tumors, Colorectal Cancer Metastatic Trial in Montréal (Modified early post-operative

        Not yet recruiting
        • Peritoneal Carcinomatosis
        • +2 more
        • Modified early post-operative intraperitoneal chemotherapy (mEPIC)
        • Montréal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Jun 12, 2023

        Hepatocellular Carcinoma Trial in Hangzhou (Anlotinib Hydrochloride)

        Terminated
        • Hepatocellular Carcinoma
        • Anlotinib Hydrochloride
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital of Medical School of Zhejiang Univ
        Aug 25, 2022

        Resectable Hepatocellular Carcinoma Trial in Houston (Nivolumab, Pegargiminase, Resection)

        Recruiting
        • Resectable Hepatocellular Carcinoma
        • Nivolumab
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 10, 2022

        Follow up After TACE by Elastography and Color Doppler.

        Not yet recruiting
        • Hepatocellular Carcinoma
        • US
        • (no location specified)
        Oct 2, 2023

        Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

        Recruiting
        • Resectable Hepatocellular Carcinoma
        • +4 more
        • Atezolizumab
        • +2 more
        • Houston, Texas
        • +1 more
        Oct 12, 2022

        Hepatocellular Carcinoma Trial in Brussels, Gent, Leuven (Chemoembolization)

        Withdrawn
        • Hepatocellular Carcinoma
        • Chemoembolization
        • Brussels, Belgium
        • +2 more
        Mar 11, 2022

        Post-orthotopic Liver Transplantation, Hepatocellular Carcinoma Recurrent Trial in Nanjing (Bevacizumab Biosimilar IBI305)

        Not yet recruiting
        • Post-orthotopic Liver Transplantation
        • Hepatocellular Carcinoma Recurrent
        • Bevacizumab Biosimilar IBI305
        • Nanjing, Jiangsu, China
          Jiangsu Province Hospital
        May 5, 2022

        Carcinoma Trial in Taoyuan City

        Recruiting
        • Carcinoma
          • Taoyuan City, Taiwan
            Chang Gung Memorial Hospital
          Feb 21, 2023

          Hepatocellular Carcinoma Stage III Trial (Transhepatic Arterial Chemotherapy And Embolization (TACE), Surgery)

          Not yet recruiting
          • Hepatocellular Carcinoma Stage III
          • Transhepatic Arterial Chemotherapy And Embolization (TACE)
          • Surgery
          • (no location specified)
          Jul 12, 2021